180 related articles for article (PubMed ID: 2928998)
1. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.
Crane J; Burgess C; Beasley R
Thorax; 1989 Feb; 44(2):136-40. PubMed ID: 2928998
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol.
Bremner P; Woodman K; Burgess C; Crane J; Purdie G; Pearce N; Beasley R
Eur Respir J; 1993 Feb; 6(2):204-10. PubMed ID: 8095240
[TBL] [Abstract][Full Text] [Related]
3. Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics.
Bremner P; Burgess C; Beasley R; Woodman K; Marshall S; Crane J; Pearce N
Respir Med; 1992 Sep; 86(5):419-23. PubMed ID: 1462021
[TBL] [Abstract][Full Text] [Related]
4. The extrapulmonary effects of inhaled hexoprenaline and salbutamol in healthy individuals.
Bremner P; Burgess C; Purdie G; Beasley R; Crane J
Eur J Clin Pharmacol; 1993; 45(1):37-9. PubMed ID: 8405027
[TBL] [Abstract][Full Text] [Related]
5. The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation.
Flatt A; Crane J; Purdie G; Kwong T; Beasley R; Burgess C
Postgrad Med J; 1990 Feb; 66(772):98-101. PubMed ID: 2349198
[TBL] [Abstract][Full Text] [Related]
6. Comparison of hypokalaemic, electrocardiographic and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects.
Lipworth BJ; Tregaskis BF; McDevitt DG
Eur J Clin Pharmacol; 1991; 40(3):255-60. PubMed ID: 2060561
[TBL] [Abstract][Full Text] [Related]
7. Partial vs full beta-receptor agonism. A clinical study of inhaled albuterol and fenoterol.
Bremner P; Siebers R; Crane J; Beasley R; Burgess C
Chest; 1996 Apr; 109(4):957-62. PubMed ID: 8635377
[TBL] [Abstract][Full Text] [Related]
8. Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.
Newnham DM; Wheeldon NM; Lipworth BJ; McDevitt DG
Thorax; 1993 Jun; 48(6):656-8. PubMed ID: 8102213
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol.
Windom H; Grainger J; Burgess C; Crane J; Pearce N; Beasley R
N Z Med J; 1990 Jun; 103(891):259-61. PubMed ID: 1972557
[TBL] [Abstract][Full Text] [Related]
10. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers.
Scheinin M; Koulu M; Laurikainen E; Allonen H
Br J Clin Pharmacol; 1987 Nov; 24(5):645-53. PubMed ID: 2829953
[TBL] [Abstract][Full Text] [Related]
11. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma.
Wong CS; Pavord ID; Williams J; Britton JR; Tattersfield AE
Lancet; 1990 Dec; 336(8728):1396-9. PubMed ID: 1978872
[TBL] [Abstract][Full Text] [Related]
12. Lack of evidence for beta-2 receptor selectivity: a study of metaproterenol, fenoterol, isoproterenol, and epinephrine in patients with asthma.
Burgess CD; Windom HH; Pearce N; Marshall S; Beasley R; Siebers RW; Crane J
Am Rev Respir Dis; 1991 Feb; 143(2):444-6. PubMed ID: 1671326
[TBL] [Abstract][Full Text] [Related]
13. The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma.
Windom HH; Burgess CD; Siebers RW; Purdie G; Pearce N; Crane J; Beasley R
Clin Pharmacol Ther; 1990 Sep; 48(3):296-301. PubMed ID: 1976051
[TBL] [Abstract][Full Text] [Related]
14. The myocardial effects of fenoterol, isoprenaline and salbutamol in normoxic and hypoxic sheep.
Pack RJ; Alley MR; Dallimore JA; Lapwood KR; Burgess C; Crane J
Int J Exp Pathol; 1994 Oct; 75(5):357-62. PubMed ID: 7999636
[TBL] [Abstract][Full Text] [Related]
15. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of fenoterol under conditions of hypoxaemia.
Bremner P; Burgess CD; Crane J; McHaffie D; Galletly D; Pearce N; Woodman K; Beasley R
Thorax; 1992 Oct; 47(10):814-7. PubMed ID: 1481183
[TBL] [Abstract][Full Text] [Related]
17. The cardiovascular effects of inhaled fenoterol alone and during treatment with oral theophylline.
Flatt A; Burgess C; Windom H; Beasley R; Purdie G; Crane J
Chest; 1989 Dec; 96(6):1317-20. PubMed ID: 2582838
[TBL] [Abstract][Full Text] [Related]
18. Comparison between the effects of inhaled isoprenaline and fenoterol on plasma cyclic AMP and heart rate in normal subjects.
Fairfax AJ; Rehahn M; Jones D; O'Malley B
Br J Clin Pharmacol; 1984 Feb; 17(2):165-70. PubMed ID: 6322828
[TBL] [Abstract][Full Text] [Related]
19. Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects.
Bennett JA; Tattersfield AE
Thorax; 1997 May; 52(5):458-64. PubMed ID: 9176539
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.
Lipworth BJ; Newnham DM; Clark RA; Dhillon DP; Winter JH; McDevitt DG
Thorax; 1995 Jan; 50(1):54-61. PubMed ID: 7886650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
